ScholarLens Back to search
2023•Unpublished venueOpen access

Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

Smita Sihag, Samuel C. Nussenzweig, Henry S. Walch, Meier Hsu, Kay See Tan, Sergio A. De La Torre, Yelena Yuriy Janjigian, Steven Brad Maron, Geoffrey Yuyat Ku, Laura H. Tang, Pari M. Shah, Abraham Jing-Ching Wu, David Randolph Jones, David B. Solit, Nikolaus D. Schultz, Karuna Ganesh, Michael F. Berger, Daniela Molena

Open full text 0 citations

Abstract

Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

About this research paper

What this paper is about

Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma

Key concepts: Esophageal adenocarcinoma, Neoadjuvant therapy, Oncology, Complete response, Medicine, Adenocarcinoma, Internal medicine, Chemotherapy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Supplementary Data from The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma — Research Paper | ScholarLens